ABBVIE INC. et al v. QILU PHARMA, INC. et al
ABBVIE INC. and ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED |
QILU PHARMA, INC., QILU ANTIBIOTICS PHARMACEUTICAL CO., LTD., APOTEX INC., FRESENIUS KABI USA, LLC and FRESENIUS KABI IPSUM SRL |
3:2024cv06759 |
June 6, 2024 |
US District Court for the District of New Jersey |
Zahid N Quraishi |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. ยง 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on June 6, 2024. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 2 Corporate Disclosure Statement by ABBVIE INC., ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED. (WALSH, LIZA) |
Filing 1 COMPLAINT against APOTEX INC., FRESENIUS KABI IPSUM SRL, FRESENIUS KABI USA, LLC, QILU ANTIBIOTICS PHARMACEUTICAL CO., LTD., QILU PHARMA, INC., filed by ABBVIE INC., ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Civil Cover Sheet, #7 AO 120 Form)(WALSH, LIZA) |
Filing fee: $ 405, receipt number ANJDC-15426706 (jr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.